GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
Clinical trial NCT00878163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00878163
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-31
- Primary completion
- 2013-01-22
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.